Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Innate Pharma S.A.
IPHA · SEC Filings
website
163
Innate Pharma S.A. is a biotechnology firm, founded in 1999 and headquartered in Marseille, France, ...
Price
1.51
Market Cap
168.17 M
Float
83.65 M
Country
FR
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about IPHA
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Innate Pharma S.A.
IPHA · SEC Filings
83.65 M
Float
1.51
Price
168.17 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 1, 2026
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 30, 2025
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 4, 2024
20-F/A
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Apr 20, 2023
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 6, 2023
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 4, 2022
News
TYPE
HEADLINE
FILED AT
6-K
Innate Pharma Reports Third Quarter 2026 Business and Financial Update
Nov 5, 2026
6-K
Innate Pharma Updates PACIFIC-9 Phase 3 Trial Readout Timing to H1 2027
Oct 27, 2026
6-K
Executive Team to Participate in Stifel Healthcare and Jefferies Global Healthcare Conferences in November 2026
Oct 21, 2026
6-K
Third-Quarter 2026 Business and Financial Update Conference Call Scheduled for November 5
Oct 20, 2026
6-K
Innate Pharma Reports First Half 2026 Business Update and Financial Results
Sep 17, 2026
6-K
Innate Pharma Reports Half-Year 2026 Financial Results
Sep 17, 2026
Prospectus
TYPE
HEADLINE
FILED AT
Registrations
TYPE
HEADLINE
FILED AT
S-8
Registration
Sep 11, 2024
F-3
SHELF | Offering amount: $200,000,000.00 EFFECTIVE
Dec 20, 2023
S-8
30,000
Jul 12, 2021
F-3
$200,000,000- EFFECTIVE
Jan 13, 2021
FWP
Registration
Oct 17, 2019
FWP
Registration
Oct 17, 2019
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Jan 17, 2024
CORRESP
Form CORRESP - Correspondence
Jan 11, 2024
LETTER
Form UPLOAD - SEC-generated letter
Dec 26, 2023
EFFECT
Form EFFECT - Notice of Effectiveness
Jan 29, 2021
CORRESP
Form CORRESP - Correspondence
Jan 27, 2021
LETTER
Form UPLOAD - SEC-generated letter
Jan 19, 2021
